(Q43953698)

28 November 2017

title

Influence of lipoprotein(a) on restenosis after femoropopliteal percutaneous transluminal angioplasty in Type 2 diabetic patients (English)

1 reference

28 November 2017

0 references

1 reference

Maca TH

1

1 reference

28 November 2017

Ahmadi R

2

1 reference

28 November 2017

Derfler K

3

1 reference

28 November 2017

Ehringer H

4

1 reference

28 November 2017

Gschwandtner ME

5

1 reference

28 November 2017

Hörl W

6

1 reference

28 November 2017

Katzenschlager R

7

1 reference

28 November 2017

Müller-Knespel E

8

1 reference

28 November 2017

Koppensteiner R

9

1 reference

28 November 2017

Schneider B

10

1 reference

28 November 2017

Stümpflen A

11

1 reference

28 November 2017

Ugurluoglu A

12

1 reference

28 November 2017

Minar E

13

1 reference

28 November 2017

publication date

1 April 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

19

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

300-306

1 reference

Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00645.X

Elevated lipoprotein(a) and increased incidence of restenosis after femoropopliteal PTA. Rationale for the higher risk of recurrence in females?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00645.X

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00645.X

Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00645.X

Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00645.X

Lp(a) concentrations in NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00645.X

Plasma apolipoprotein (a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00645.X

Medial artery calcification predicts cardiovascular mortality in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00645.X

Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00645.X

The effect of long-term glycaemic control on serum lipoprotein(a) levels in patients with Type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00645.X

Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00645.X

Oxidative stress and diabetic vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00645.X

Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00645.X

10.1046/J.1464-5491.2002.00645.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference